Amyloid diseases, including Alzheimer's, Parkinson's, type-2 diabetes and other life-threatening diseases, involve pathologic deposits of normally soluble proteins or peptides as insoluble amyloid fibrils. When this happens in vital organs, such as the brain, kidney, liver and heart, it causes…
Read More
Promising immunotherapy uses cancer-killing cells to destroy malignant tumors
Researchers at McMaster University have developed a promising new cancer immunotherapy that uses cancer-killing cells genetically engineered outside the body to find and destroy malignant tumors. The modified "natural killer" cells can differentiate between cancer cells and healthy cells that…
Read More
Systolic blood pressure above 120 mmHg increases rate of cardiovascular disease
An estimated 1.13 billion people worldwide have hypertension or high blood pressure, and two-thirds of these individuals are living in low- and middle-income countries. Blood pressure is the force manifested by circulating blood against the walls of the body’s arteries,…
Read More
RUDN University doctors find alterations in serum amino acid profile in children with ADHD
RUDN University doctors found alterations in serum amino acid profile in children with attention deficit hyperactivity disorder (ADHD). The findings will help to understand the mechanism of the disorder and develop new treatment strategies. The study is published in the…
Read More
Research provides insights into why COVID-19 patients develop severe blood clots
Scientists have identified how and why some Covid-19 patients can develop life-threatening clots, which could lead to targeted therapies that prevent this from happening. The work, led by researchers from RCSI University of Medicine and Health Sciences, is published in…
Read More
A history of blood clots is not usually any reason to avoid the AstraZeneca vaccine
As hematologists, we look after many patients who have had blood clots in the past or take blood thinners. They often ask: “should I have the AstraZeneca vaccine?” The answer is usually a definitive “yes.” The blood clots we’ve seen…
Read More
Association between blood plasma lipids and risk of Alzheimers disease
Latest research from UNSW Sydney’s Center for Healthy Brain Aging (CHeBA) has uncovered new insight into the underlying mechanisms of Alzheimer’s disease. The findings, published in Translational Psychiatry, examined differences between the plasma lipidome of people with Alzheimer’s disease and…
Read More
Antibody treatment reactivates the immune defense in patients with advanced-stage cancer
Researchers at the University of Turku, Finland, showed that the antibody treatment reactivates the immune defense in patients with advanced-stage cancer. The treatment alters the function of the body's phagocytes and facilitates extensive activation of the immune system. The immune…
Read More
Blood donations ARE safe amid COVID-19 pandemic, NIH study finds
Blood donations ARE safe amid COVID-19 pandemic: NIH study finds 0.001% risk of patients receiving a transfusion with trace amounts of coronavirus A new NIH study says Americans can safely receive blood donations without the worry of catching COVID-19 Results…
Read More
Low on antibodies, blood cancer patients can fight off COVID-19 with T cells
Antibodies aren’t the only immune cells needed to fight off COVID-19—T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19 published…
Read More